T-CELL LYMPHOMA REFRACTORY

T-CELL LYMPHOMA REFRACTORY was reported 35 times

T-CELL LYMPHOMA REFRACTORY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Topoisomerase Inhibitor [EPC] 24 0.0003
1 Alkylating Drug [EPC] 27 0.0001
2 Platinum-based Drug [EPC] 17 0.0001
3 Integrin Receptor Antagonist [EPC] 3 0.0000
4 CD20-directed Cytolytic Antibody [EPC] 7 0.0000
5 Leukocyte Growth Factor [EPC] 3 0.0000
6 Corticosteroid [EPC] 27 0.0000
7 Folate Analog Metabolic Inhibitor [EPC] 7 0.0000
8 Tumor Necrosis Factor Blocker [EPC] 10 0.0000
9 Proteasome Inhibitor [EPC] 1 0.0000
10 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000